Jiang Xiaohui, Yu Meihong, Zhu Taiping, Lou Lulu, Chen Xu, Li Qian, Wei Danhong, Sun Renhua
Department of Critical Care Medicine, Chun'an First People's Hospital (Zhejiang Provincial People's Hospital, Chun'an Branch), Hangzhou 311700, P.R. China; Department of Critical Care Medicine, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou 310014, P.R. China.
Department of Critical Care Medicine, Chun'an First People's Hospital (Zhejiang Provincial People's Hospital, Chun'an Branch), Hangzhou 311700, P.R. China.
Mol Ther Nucleic Acids. 2020 Mar 6;19:179-189. doi: 10.1016/j.omtn.2019.10.036. Epub 2019 Nov 13.
Inflammatory mediators play a key role in the pathogenesis of acute respiratory distress syndrome (ARDS). In this study, we aimed to explore the involvement of the Kcnq1 opposite strand/antisense transcript 1 (Kcnq1ot1)/miR-381-3p/E26 transformation-specific proto-oncogene 2 (ETS2) axis in inflammation of lipopolysaccharide (LPS)-induced ARDS. Microarray analysis revealed ETS2 as an upregulated gene in ARDS. Then, a LPS-induced ARDS mouse model was constructed, with a series of gain- or loss-of-function experiments conducted to evaluate the lung function and neutrophil extracellular trap (NET) formation in lung tissue and determine the neutrophil number, myeloperoxidase (MPO) activity, and inflammatory factor levels in bronchoalveolar lavage fluid (BALF). As the results revealed, downregulated expression of ETS2 resulted in improved lung function, decreased NETs, MPO activity, and levels of interleukin (IL)-6 and tumor necrosis factor alpha (TNF-α), as well as increased IL-10 level. Then, the assays of dual-luciferase reporter, RNA-binding protein immunoprecipitation (RIP), and RNA pull-down were performed to validate that Kcnq1ot1 promoted ETS2 expression by competitively binding to miR-381-3p. Meanwhile, it was also found that Kcnq1ot1 silencing reversed the promotive effect of EST2 on ARDS. Our results provide evidence that Kcnq1ot1 silencing may reduce the inflammatory response in LPS-induced ARDS via inhibition of miR-381-30-dependent ETS2, thereby presenting new molecular understanding for the development of ARDS.
炎症介质在急性呼吸窘迫综合征(ARDS)的发病机制中起关键作用。在本研究中,我们旨在探讨钾离子通道蛋白家族成员1反义链/反义转录本1(Kcnq1ot1)/微小RNA-381-3p/ E26转化特异性原癌基因2(ETS2)轴在脂多糖(LPS)诱导的ARDS炎症中的作用。基因芯片分析显示ETS2是ARDS中上调的基因。然后,构建LPS诱导的ARDS小鼠模型,进行一系列功能获得或缺失实验,以评估肺功能以及肺组织中中性粒细胞胞外陷阱(NET)的形成,并确定支气管肺泡灌洗液(BALF)中的中性粒细胞数量、髓过氧化物酶(MPO)活性和炎症因子水平。结果显示,ETS2表达下调可改善肺功能,减少NETs、MPO活性以及白细胞介素(IL)-6和肿瘤坏死因子α(TNF-α)水平,并增加IL-10水平。随后,进行双荧光素酶报告基因检测、RNA结合蛋白免疫沉淀(RIP)和RNA下拉实验,以验证Kcnq1ot1通过竞争性结合miR-381-3p促进ETS2表达。同时,还发现沉默Kcnq1ot1可逆转EST2对ARDS的促进作用。我们的结果表明,沉默Kcnq1ot1可能通过抑制miR-381-30依赖性ETS2来减轻LPS诱导的ARDS中的炎症反应,从而为ARDS的发展提供新的分子认识。